Besides, the elevated protein level of IL-18 in the immune-stromal cells of cancer tissues, rather than tumor cells, was found closely associated with poor 5-year RFS, which indicates that IL-18 may be a key target for improving the long-term prognosis of breast cancer patients in the future. This evidence concerns the gene IL18 and breast carcinoma.